The story of the erectile dysfunction drug presents a intricate picture for shareholders. While the initial introduction generated substantial profits, the lapse of its intellectual property protection opened the https://naturalbookmarks.com/story21691048/viagra-and-the-pharmaceutical-industry-a-risky-investment